| Jan 15, 2010
| 8:48 PM
NEW YORK - Johnson & Johnson issued a massive recall Friday of over-the-counter drugs including Tylenol, Motrin and St. Joseph's aspirin because of a moldy smell that has made people sick.
It was the second such recall in less than a month because of the...
| Jan 19, 2010
| 1:42 AM
NEW YORK (AP) - Johnson & Johnson is again expanding a recall of Tylenol caplets due to a moldy smell that made some users sick. The company says the problem also affects some lots of its fever and pain drug Motrin.
The company's McNeil Consumer...
| Feb 8, 2010
| 6:12 PM
Nassau County will be encouraging mothers-to-be to get information about prenatal care delivered right to their cell phone inbox.
With Text4baby by Syniverse, mothers across the United States can sign up for free to receive weekly updates on a variety of...
| Jul 9, 2009
The next generation of health professionals is sure to be in hot demand as America's population grows in age and numbers, but they won't get there alone.
Someone has to teach the nation's future medical personnel the skills necessary to serve on the...
| Sep 24, 2009
Johnson & Johnson's McNeil unit said Thursday it is voluntarily recalling 57 lots of infants' and children's liquid Tylenol products because of possible bacterial contamination.
The products being recalled were made between April and June and include...
| Jul 9, 2010
| 5:14 PM
Johnson and Johnson is expanding its recall of over-the-counter medicines because of a musty or moldy smell.
This latest recall includes certain types of Children's Tylenol, adult-strength Benadryl, Motrin I-B, Tylenol Extra Strength, Tylenol Day and...
| Jul 19, 2010
| 3:09 PM
Federal regulators have filed a critical report on the Johnson and Johnson plant in East Lampeter Township, Lancaster County. Last April New Jersey based healthcare company shut down a suburban Philadelphia plant linked to eight recalls of Tylenol and...
| Dec 20, 2000
For most of its history, the United States Food and Drug Administration approved new prescription medicines at a grudging pace, paying daily homage to the physician's creed, "First, do no harm."
Then in the early 1990s, the demand for AIDS drugs...
| Dec 20, 2000
In mid-1993, FDA officials prepared to approve Propulsid, a drug that eased nighttime heartburn. But a sign of danger loomed.
FDA medical officer Andre Dubois noted that 48 of 1,993, or 2.4%, of the patients who took Propulsid in U.S. studies experienced...
| Jul 29, 2001
President Bush's decision on whether the federal government will fund embryonic stem cell research could open the door to a new generation of budding scientists or perhaps send many of them packing in search of a more favorable research climate or more...